Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount Drugs.
نویسنده
چکیده
Drug companies push to rein in 340B discount drugs.
منابع مشابه
Hospital Group Wants to Expand Section 340B Drug Purchase Program.
the House Ways and Means Committee on September 23. He explained that this would allow the hospitals to further stretch their limited resources and relieve them of the burden of carrying two separate inventories and pricing structures for inpatient and outpatient drugs. Theoretically, the Ways and Means Committee, in conjunction with Energy and Commerce and Senate Finance, could initiate author...
متن کاملHealth Care Reform Bill Expands Access to Section 340B Discounted Drugs for Hospitals.
ally 25% to 40% of the average manufacturer’s price (AMP). That differential goes into the hospital’s pocket, totaling as much as $10 million per year for some larger hospital systems. That dab of honey on the bottom line of a safety net hospital (or federal clinic) is especially sweet these days, with public hospitals beset by state cutbacks in Medicaid funding at the same time that their unco...
متن کاملFinal Rule on ACOs Raises Concerns About Medication Cost-Shifting: Pharmacists to Play a Secondary Role in New Physician-Hospital Organizations.
the Academy of Managed Care Pharmacy. Of course, the number of program integrity “watchdogs” at the CMS and other federal health agencies is decreasing, with federal budget cuts being the order of the day. Even in the halcyon days of federal spending with bigger staffs, Department of Health and Human Services watchdogs were rather passive policemen. The Office of Pharmacy Affairs, which adminis...
متن کاملHospital outpatient pharmacies win higher medicare payments for 2011: but they are not yet recovering overhead costs for expensive drugs.
drugs. In 2011, that CMS “Robin Hood” move resulted in an additional $200 million being tossed into the separately payable-drug reimbursement pool. As a result, the average reimbursement went from a rate of ASP minus 1% (which is what the CMS formula would have dictated) to the ASP plus 5%. That is 1% higher than the 2010 amount. Although hospitals are appreciative of the increase, they point o...
متن کاملPolicy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.
Congress established Section 340B of the Public Health Service Act—commonly referred to as the 340B Drug Pricing Program—in 1992.1 The 340B Drug Pricing Program requires manufacturers to provide substantial discounts for sales of covered drugs to covered entities as a prerequisite to qualifying for Medicaid reimbursement. Covered hospitals and other covered entities must limit the use of discou...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 38 9 شماره
صفحات -
تاریخ انتشار 2013